Roche Media News

Roche launches the Liver Disease Panel, the first suite of certified algorithms to support Chronic Liver Disease management

5 days ago

Roche introduces the first comprehensive library of certified healthcare algorithms to support...

Roche to present new data at ASCO 2026, reinforcing giredestrant's potential to transform the treatment paradigm in early breast cancer

13 days ago

New giredestrant data from the lidERA study on its potential as a...

Roche receives CE mark for new blood test to detect Alzheimer's pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217)

20 days ago

Elecsys® pTau217 is the first blood test for Alzheimer’s disease pathology with...

Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics

25 days ago

PathAI’s best-in-class Image Management System (IMS) with advanced AI analysis and workflow...

Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026

about 1 month ago

New real-world data confirm Vabysmo’s potent retinal drying in nAMD and DMEKey...

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc

about 1 month ago

Group sales were +6% at constant exchange rates (CER)1, -5% when reported...

Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS

about 1 month ago

Late-breaking Phase III FENhance 1 and 2 study results showed superiority of...

Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD

about 1 month ago

Phase III METEOROID study met its primary endpoint in patients with myelin...

FDA accepts application for Roche’s Gazyva/Gazyvaro for the treatment of the most common form of lupus

about 1 month ago

Filing acceptance based on phase III ALLEGORY data for Gazyva/Gazyvaro showing a...

Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis

about 2 months ago

The Elecsys NfL blood test detects neuroaxonal damage associated with neuroinflammation in...

Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply

2 months ago

The cobas MPX-E test provides four critical results (for HIV, HCV, HBV...

https://www.roche.com/media/releases/med-cor-2026-03-23

2 months ago